File Download
Patent History
- ApplicationPC T/CN2011000322 2011-02-28
- PublicationWO 2011103774 2011-09-01
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: PHARMACEUTICAL COMPOSITION AND USE THEREOF IN MANUFACTURING MEDICAMENTS FOR TREATING RESPIRATORY DISEASES
| Title | PHARMACEUTICAL COMPOSITION AND USE THEREOF IN MANUFACTURING MEDICAMENTS FOR TREATING RESPIRATORY DISEASES |
|---|---|
| Priority Date | 2010-02-26 US 12/308597P |
| Inventors | |
| Issue Date | 2011 |
| Citation | WO Published patent application WO 2011103774. World Intellectual Property Organization (WIPO), PatentScope, 2011 How to Cite? |
| Abstract | Composition including a neutrophil elastase (NE)-targeting agent that counters the pathologic elements of respiratory inflammation is provided. NE-targeting agents primarily disrupt the association between NE and shed ectodomains of Syn-1, resulting in inhibition of the NE by protease inhibitors or anti-elastases. Non-anticoagulant heparin derivatives or fragments are exemplary NE-targeting agents. The composition preferably includes a carrier, such as chitosan or lactose in dry powder formulations, to facilitate delivery of the active agent. Use of the composition in manufacturing medicaments for treating respiratory diseases is also disclosed. |
| Persistent Identifier | http://hdl.handle.net/10722/177157 |
| References |
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2012-11-30T08:39:14Z | - |
| dc.date.available | 2012-11-30T08:39:14Z | - |
| dc.date.issued | 2011 | - |
| dc.identifier.citation | WO Published patent application WO 2011103774. World Intellectual Property Organization (WIPO), PatentScope, 2011 | en_HK |
| dc.identifier.uri | http://hdl.handle.net/10722/177157 | - |
| dc.description.abstract | Composition including a neutrophil elastase (NE)-targeting agent that counters the pathologic elements of respiratory inflammation is provided. NE-targeting agents primarily disrupt the association between NE and shed ectodomains of Syn-1, resulting in inhibition of the NE by protease inhibitors or anti-elastases. Non-anticoagulant heparin derivatives or fragments are exemplary NE-targeting agents. The composition preferably includes a carrier, such as chitosan or lactose in dry powder formulations, to facilitate delivery of the active agent. Use of the composition in manufacturing medicaments for treating respiratory diseases is also disclosed. | en_HK |
| dc.title | PHARMACEUTICAL COMPOSITION AND USE THEREOF IN MANUFACTURING MEDICAMENTS FOR TREATING RESPIRATORY DISEASES | en_HK |
| dc.type | Patent | en_US |
| dc.description.nature | published_or_final_version | en_US |
| dc.contributor.inventor | Shum, DKY | en_HK |
| dc.contributor.inventor | Ip, MSM | en_HK |
| dc.contributor.inventor | Chan, Chi Hang | en_HK |
| dc.contributor.inventor | Leung, Valeria On Yue | en_HK |
| patents.identifier.application | PC T/CN2011000322 | en_HK |
| patents.description.assignee | UNIV HONG KONG [CN]; SHUM DAISY KWOK YAN [CN]; IP MARY SAU MAN [CN]; CHAN CHI HANG [CN]; LEUNG VALERIA ON YUE [CN] | en_HK |
| patents.description.country | World Intellectual Property Organization (WIPO) | en_HK |
| patents.date.publication | 2011-09-01 | en_HK |
| dc.relation.references | WO 9906025 (A1) 1999-02-11 | en_HK |
| dc.relation.references | CN 1197587 (C) 2005-04-20 | en_HK |
| dc.relation.references | CN 1327795 (A) 2001-12-26 | en_HK |
| dc.relation.references | CN 1278820 (A) 2001-01-03 | en_HK |
| dc.relation.references | CN 1287852 (C) 2006-12-06 | en_HK |
| dc.relation.references | CN 1306435 (A) 2001-08-01 | en_HK |
| patents.date.application | 2011-02-28 | en_HK |
| patents.date.priority | 2010-02-26 US 12/308597P | en_HK |
| patents.description.cc | WO | en_HK |
| patents.identifier.publication | WO 2011103774 | en_HK |
| patents.relation.family | US 2011212181 (A1) 2011-09-01 | en_HK |
| patents.relation.family | WO 2011103774 (A1) 2011-09-01 | en_HK |
| patents.description.kind | A1 | en_HK |
| patents.type | Patent_published | en_HK |